|
| 37752309 | Risk perception and intended behavior change after uninformative genetic results for adult-onset hereditary conditions in unselected patients. | Eur J Hum Genet | 2024 |
| 36451272 | Modeling the impact of data sharing on variant classification. | J Am Med Inform Assoc | 2023 |
| 37751715 | ConnectMyVariant: An Innovative Use of Technology and Social Networks to Realize the Benefits of Cascade Screening. | Public Health Genomics | 2023 |
| 37905042 | Assigning credit where it's due: An information content score to capture the clinical value of Multiplexed Assays of Variant Effect. | bioRxiv | 2023 |
| 37897815 | Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice Survey. | JCO Precis Oncol | 2023 |
| 37604133 | Factors Influencing Genetic Screening Enrollment among a Diverse, Community-Ascertained Cohort. | Public Health Genomics | 2023 |
| 37384863 | Practices and Views of US Oncologists and Genetic Counselors Regarding Patient Recontact After Variant Reclassification: Results of a Nationwide Survey. | JCO Precis Oncol | 2023 |
| 37079361 | Extended Family Outreach in Hereditary Cancer Using Web-Based Genealogy, Direct-to-Consumer Ancestry Genetics, and Social Media: Mixed Methods Process Evaluation of the ConnectMyVariant Intervention. | JMIR Cancer | 2023 |
| 36971772 | Laboratory perspectives in the development of polygenic risk scores for disease: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2023 |
| 37069702 | Diagnostic yield of genetic screening in a diverse, community-ascertained cohort. | Genome Med | 2023 |
| 37293588 | Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey. | Front Oncol | 2023 |
| 36753473 | Using species richness calculations to model the global profile of unsampled pathogenic variants: Examples from BRCA1 and BRCA2. | PLoS One | 2023 |
| 36426404 | A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genes. | Cancer Med | 2023 |
| 36600593 | Optimising clinical care through <i>CDH1</i>-specific germline variant curation: improvement of clinical assertions and updated curation guidelines. | J Med Genet | 2023 |
| 34923710 | Harmonizing variant classification for return of results in the All of Us Research Program. | Hum Mutat | 2022 |
| 35365779 | Implementation of pharmacogenomic clinical decision support for health systems: a cost-utility analysis. | Pharmacogenomics J | 2022 |
| 35628017 | Socioeconomic Status and Interest in Genetic Testing in a US-Based Sample. | Healthcare (Basel) | 2022 |
| 33864888 | Molecular diagnosis of childhood immune dysregulation, polyendocrinopathy, and enteropathy, and implications for clinical management. | J Allergy Clin Immunol | 2022 |
| 35225377 | An algorithm for optimal testing in co-segregation analysis. | Hum Mutat | 2022 |
| 34863587 | Inherited TP53 Variants and Risk of Prostate Cancer. | Eur Urol | 2022 |
| 32579152 | Relationship between genetic knowledge and familial communication of CRC risk and intent to communicate CRCP genetic information: insights from FamilyTalk eMERGE III. | Transl Behav Med | 2021 |
| 33848333 | Multiplexing mutation rate assessment: determining pathogenicity of Msh2 variants in Saccharomyces cerevisiae. | Genetics | 2021 |
| 33591484 | The FamilyTalk randomized controlled trial: patient-reported outcomes in clinical genetic sequencing for colorectal cancer. | Cancer Causes Control | 2021 |
| 34793697 | Closing the gap: Systematic integration of multiplexed functional data resolves variants of uncertain significance in BRCA1, TP53, and PTEN. | Am J Hum Genet | 2021 |
| 34250417 | Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative. | JCO Precis Oncol | 2021 |
| 34007000 | One in seven pathogenic variants can be challenging to detect by NGS: an analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementation. | Genet Med | 2021 |
| 33979874 | Infobuttons for Genomic Medicine: Requirements and Barriers. | Appl Clin Inform | 2021 |
| 33373667 | Design of a study to implement population-based risk assessment for hereditary cancer genetic testing in primary care. | Contemp Clin Trials | 2021 |
| 33455827 | What improves the likelihood of people receiving genetic test results communicating to their families about genetic risk? | Patient Educ Couns | 2021 |
| 32997669 | Effects of germline and somatic events in candidate BRCA-like genes on breast-tumor signatures. | PLoS One | 2020 |
| 31916645 | Exploring relatives' perceptions of participation, ethics, and communication in a patient-driven study for hereditary cancer variant reclassification. | J Genet Couns | 2020 |
| 31911673 | Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots". | Genet Med | 2020 |
| 32886903 | Complexities of Next-Generation Sequencing in Solid Tumors: Case Studies. | J Natl Compr Canc Netw | 2020 |
| 32686686 | Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival. | Nat Commun | 2020 |
| 30636062 | Patients' perspectives of variants of uncertain significance and strategies for uncertainty management. | J Genet Couns | 2019 |
| 31843900 | Characterization of splice-altering mutations in inherited predisposition to cancer. | Proc Natl Acad Sci U S A | 2019 |
| 31862013 | Recommendations for the collection and use of multiplexed functional data for clinical variant interpretation. | Genome Med | 2019 |
| 30027524 | Experiences of patients seeking to participate in variant of uncertain significance reclassification research. | J Community Genet | 2019 |
| 30019097 | Modified capture-recapture estimates of the number of families with Lynch syndrome in Central Ohio. | Fam Cancer | 2019 |
| 31246251 | Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers. | JAMA Oncol | 2019 |
| 31296927 | Exploring the effect of ascertainment bias on genetic studies that use clinical pedigrees. | Eur J Hum Genet | 2019 |
| 31317629 | Insurance coverage does not predict outcomes of genetic testing: The search for meaning in payer decisions for germline cancer tests. | J Genet Couns | 2019 |
| 31400517 | Clinical exome sequencing vs. usual care for hereditary colorectal cancer diagnosis: A pilot comparative effectiveness study. | Contemp Clin Trials | 2019 |
| 31036281 | Technical, Biological, and Systems Barriers for Molecular Clinical Decision Support. | Clin Lab Med | 2019 |
| 31163102 | Patient goals, motivations, and attitudes in a patient-driven variant reclassification study. | J Genet Couns | 2019 |
| 31075532 | Incorporating user feedback in the design of a genetics analysis tool: A two-part approach. | J Biomed Inform | 2019 |
| 30374176 | Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance. | Genet Med | 2019 |
| 28695303 | A comparison of cosegregation analysis methods for the clinical setting. | Fam Cancer | 2018 |
| 32913991 | Postmortem Somatic Sequencing of Tumors From Patients With Suspected Lynch Syndrome Has Clinical Utility for Surviving Relatives. | JCO Precis Oncol | 2018 |
| 29887214 | Using Somatic Mutations from Tumors to Classify Variants in Mismatch Repair Genes. | Am J Hum Genet | 2018 |